A top pharma sponsor approached Science 37 to conduct a Phase 4 clinical trial for patients with diabetes in Demark, requiring continuous data collection via biosensors for 12 weeks. The Science 37 Metasite™ was used to operationalize the end-to-end clinical trial, from patient recruitment and eConsent to the collection and aggregation of data.
See how Science 37’s innovative trial design supported patients remotely and provided the sponsor with real-time access to sensor data.
Submit the form to watch the case study video.